Oligomerization Partially Explains the Lowering of Aβ42 in Alzheimer’s Disease Cerebrospinal Fluid.
- Published in:
- Neurodegenerative Diseases, 2009, v. 6, n. 4, p. 139, doi. 10.1159/000225376
- By:
- Publication type:
- Article
Works matching IS 16602854 AND DT 2009 AND VI 6 AND IP 4
Results: 4
1
2
Evaluation of the Size and Area of the Corpus Callosum with the Osiris Method in Alzheimer’s Disease.
- Published in:
- Neurodegenerative Diseases, 2009, v. 6, n. 4, p. 148, doi. 10.1159/000225375
- By:
- Publication type:
- Article
3
Huntington’s Disease – New Perspectives Based on Neuroendocrine Changes in Rodent Models.
- Published in:
- Neurodegenerative Diseases, 2009, v. 6, n. 4, p. 154, doi. 10.1159/000225377
- By:
- Publication type:
- Article
4
List of Drugs in Development for Neurodegenerative Diseases: Update June 2009.
- Published in:
- Neurodegenerative Diseases, 2009, v. 6, n. 4, p. 165, doi. 10.1159/000232576
- By:
- Publication type:
- Article